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Abstract
Introduction Urinary interleukin-18 (IL-18) measured during the
immediate postoperative period could be a promising predictor
of acute kidney injury following adult cardiac surgery.
Methods In a single-centre prospective observational cohort
study, we enrolled 100 adult cardiac surgical patients
undergoing cardiopulmonary bypass at a tertiary hospital. We
measured the urinary concentration of IL-18 and creatinine
preoperatively, on arrival in the intensive care unit, and 24 hours
postoperatively. We assessed urinary IL-18 concentration and
urinary IL-18/urinary creatinine ratio in relation to the
postoperative development of acute kidney injury defined as an
increase in serum creatinine of greater than 50% from
preoperative to postoperative peak value within 48 hours after
surgery.
Results Twenty patients developed acute kidney injury. On
arrival in the intensive care unit and at 24 hours postoperatively,
urinary IL-18 (median [interquartile range]) was not different in
patients who subsequently developed acute kidney injury
compared with those who did not: on arrival in the intensive care
unit (168 [717] versus 104 [256] pg/mL; P = 0.70) and at 24
hours (195 [483] versus 165 [246] pg/mL; P = 0.47). On arrival
in the intensive care unit (area under the curve for the receiver
operating characteristic curve [AUC-ROCC] 0.53, 95%
confidence interval [CI] 0.38 to 0.68; P = 0.70) and at 24 hours
postoperatively (AUC-ROCC 0.55, 95% CI 0.40 to 0.71; P =
0.48), urinary IL-18 was not better than chance in predicting
acute kidney injury. All findings were confirmed when urinary IL-
18 was adjusted for urinary creatinine. Urinary IL-18 correlated
with duration of cardiopulmonary bypass (P < 0.001).
Conclusion In adults, early postoperative measurement of
urinary IL-18 appears not to be valuable in identifying patients
who develop acute kidney injury after cardiac surgery, but rather
represents a nonspecific marker of cardiopulmonary bypass-
associated systemic inflammation.
Introduction
Acute kidney injury (AKI) is a serious and frequent complica-
tion of cardiac surgery [1-3]. Cardiac surgery is the second
most frequent cause of AKI worldwide among critically ill
patients [2]. There is a need for early and specific renal
biomarkers that would enable the early prediction of AKI and
timely intervention [4]. There is evidence that urinary inter-
leukin-18 (IL-18) – a proinflammatory cytokine released in
response to injury to renal tubular epithelial cells and demon-
strated in activated macrophages – might act as an earlier
biomarker than serum creatinine in predicting AKI in critically
ill adult patients [5-8]. However, in the prediction of contrast-
induced nephropathy in adult patients, the value of urinary IL-
18 is controversial [9,10]. Recently, urinary IL-18 was reported
to predict AKI in patients receiving a kidney transplant [11], in
critically ill children [12], and in paediatric cardiac surgery
[13]. Despite such a promising observation in children, the
predictive performance of the measurement of urinary IL-18
immediately after surgery has not yet been assessed in adult
cardiac surgical patients undergoing cardiopulmonary bypassPage 1 of 8
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Accordingly, in this prospective observational cohort study,
we sought to investigate whether urinary IL-18 could serve as
an early predictive renal biomarker in adult patients undergo-
ing cardiac surgery. We hypothesised that urinary IL-18 meas-
ured during the immediate postoperative period would be a
promising predictor of AKI following adult cardiac surgery.
Materials and methods
Patient population
In a prospective observational cohort study, we screened 114
adult patients who underwent cardiac surgery necessitating
the use of CPB at a tertiary hospital. We excluded patients
undergoing emergency operations (time between hospital
admission to operation of less than 24 hours) or an operation
without the use of CPB, patients with end-stage renal disease
(serum creatinine of greater than 300 μmol/L), kidney trans-
plant patients, and patients under the age of 18. The local
institutional review board of the Austin Hospital, Melbourne,
approved this investigation and written informed consent was
obtained. This study was in compliance with the Declaration of
Helsinki. Clinical practice was not changed or modified for the
purpose of the study.
Outcomes
In this study, we aimed to examine the predictive performance
of urinary IL-18 concentration and of urinary IL-18/urinary cre-
atinine ratio on arrival in the intensive care unit (ICU) and at 24
hours after commencement of CPB for the prediction of AKI
defined as an increase in serum creatinine of greater than 50%
within 48 hours postoperatively (Figures 1, 2, 3, 4). Additional
renal outcome measures included AKI defined as a greater
than 25% increase in creatinine, changes in creatinine to 72
hours or 5 days, sustained increase of greater than 50%, sus-
tained increase of greater than 25%, or AKI graded according
to a variety of RIFLE (Risk of renal dysfunction, Injury to the kid-
ney, Failure of kidney function, Loss of kidney function, and
End-stage kidney disease) criteria [14]. We defined 'sus-
tained' as at least two consecutive significantly increased
serum creatinine values. In virtually all patients, sampling at 6
hours after commencement of CPB closely corresponded to
arrival of the patient in the ICU. We refer to this time point of
sampling as 'arrival in ICU'.
Sampling and measurement of renal function markers
As part of the study protocol, for the measurement of urinary
IL-18 and urinary creatinine, we obtained urine preoperatively
(immediately before induction of anaesthesia), on arrival in
ICU, and at 24 hours after commencement of CPB. Samples
were spun at 1,500 g for 10 minutes, and the supernatants
were stored in equal volumes within 10 minutes at -80°C. We
adjusted urinary IL-18 concentration for urinary creatinine con-
centration (urinary IL-18/urinary creatinine ratio). For the meas-
urement of serum creatinine, we collected blood samples
preoperatively and at 24, 48, and 72 hours after commence-
Figure 1
Performance of urinary interleukin-18 on arrival in the intensive care unit as a predictor of acute kidney injury according to an creas  in s r m cre tinine of greater ha  50% from preoperative o postoperative peakvalue within 48 hou s after commencement of cardiopulmonary by ass(n = 20)f r an e of urinary interleukin-18 on arrival in the inte iv  care unit  a
predictor of acute kidney injury according to an increase in serum creatinine 
of greater than 50% from preoperative to postoperative peak value within 48 
hours after commencement of cardiopulmonary bypass (n = 20). AUC-
ROCC, area under the curve for the receiver operating characteristic curve; 
CI, confidence interval.
Figure 2
Performance of urinary interleukin-18 at 24 hours after commencement of cardiopulm na y bypass as a predic or of acute kidney injury accord-ing t  an increase in serum creatinine of greate  than 50% from pre p-erative t  postop rativ  p ak v lue within 48 hours after comme cem nt of cardiopulmo ary bypass (n = 20)f ance of urinary interleukin-18 at 24 h urs af r comme c ent f 
cardiopulmonary bypass as a predictor of acute kidney injury according to 
an increase in serum creatinine of greater than 50% from preoperative to 
postoperative peak value within 48 hours after commencement of cardiopul-
monary bypass (n = 20). AUC-ROCC, area under the curve for the receiver 
operating characteristic curve; CI, confidence interval.Page 2 of 8
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enzyme-linked immunosorbent assay using matched antibody
pairs and recombinant standards (MBL International, Woburn,
MA, USA). The inter- and intra-assay coefficients of variation of
urinary IL-18 measurement were less than 8%. Serum and uri-
nary creatinine was measured using the Jaffé method (Beck-
man Coulter SYNCHRON LX System; Beckman Coulter, Inc.,
Fullerton, CA, USA). The laboratory investigators were blinded
to the sample sources and clinical outcomes.
Data collection
Data collected preoperatively included age, gender, and infor-
mation on major comorbidities. We collected intraoperative
data on type of cardiac surgery and duration of CPB. Finally,
we recorded hourly fluid intake and urinary output from start to
24 hours after commencement of CPB (as a urinary catheter
was used in all patients during this time). Urinary output was
maintained at 0.5 to 1 mL/kg per hour by fluid administration
and by using furosemide if necessary.
Statistical analysis
We assessed data for normal distribution using histograms.
When data were normally distributed, we present variables as
mean ± standard deviation and used the t test for comparison
of patients developing AKI with those who did not. When data
were not normally distributed, we present variables as median
with 25th to 75th percentiles and used the Mann-Whitney U
test for comparison of both patient groups. When multiple
testing occurred, we applied Bonferroni correction. For cate-
gorical data, we performed two group comparisons using the
chi-square test or Fisher exact test when the expected value
was less than 5. Urinary IL-18 was assessed for its ability to
detect AKI as defined by nonparametric calculation of the area
under the curve for the receiver operating characteristic curve
(AUC-ROCC) on arrival in ICU and at 24 hours after com-
mencement of CPB. An AUC-ROCC value of 0.90 to 1.0 indi-
cates excellent, 0.80 to 0.89 good, 0.70 to 0.79 fair, 0.60 to
0.69 poor, and 0.50 to 0.59 no useful performance. Urinary IL-
18 concentration was correlated with duration of CPB (Spear-
man correlation). A two-sided P value of 0.05 was considered
to be statistically significant. We used SPSS version 15.0
(SPSS Inc., Chicago, IL, USA) and MedCalc version 9.3.9.0
(MedCalc Software, Mariakerke, Belgium).
Results
We excluded 14 patients and analysed data from 100 adult
cardiac surgical patients. None of the patients enrolled
received contrast dye within 72 hours preoperatively. Arrival in
the ICU was 5.5 ± 1.9 hours after commencement of CPB.
Patient characteristics are presented in Table 1. Twenty
patients developed AKI. Patients developing AKI were older
and were more likely to present with chronic obstructive pul-
monary disease, peripheral vascular disease, atrial fibrillation,
and arterial hypertension. Within 48 hours postoperatively, the
peak serum creatinine concentration was 182.3 ± 56.3 μmol/
Figure 3
Performance of urinary interleukin-18/urinary creatinine ratio on arrival in the intensive care unit as a predictor of cute kid ey injury acco ding to an i crease in s r m cr atinine of greater than 50% from preopera-ive to postop rative peak v l e w thin 48 hours fter com encem tof cardiopulm a y byp s (n = 20)f ance of urina y in e leukin-18/urinary c eatinine rati  n arriv l in the
intensive care unit as a predictor of acute kidney injury according to an 
increase in serum creatinine of greater than 50% from preoperative to post-
operative peak value within 48 hours after commencement of cardiopulmo-
nary bypass (n = 20). AUC-ROCC, area under the curve for the receiver 
operating characteristic curve; CI, confidence interval.
Figure 4
Performance of urinary interleukin-18/urinary creatinine ratio at 24 hours after comme cement of cardiopulmonary bypass as a predictor of acute kidney injury according to an increase in serum creatinine of greater than 50% from pr opera ive to postoper ve pe k v lu  wi hin 48 hours fter comm nc me t of c rdiopulmonary by ass (n = 20)f r ance f urinar  i t rleukin-18/u inary creati ine atio at 24 hours 
after commencement of cardiopulmonary bypass as a predictor of acute kid-
ney injury according to an increase in serum creatinine of greater than 50% 
from preoperative to postoperative peak value within 48 hours after com-
mencement of cardiopulmonary bypass (n = 20). AUC-ROCC, area under 
the curve for the receiver operating characteristic curve; CI, confidence 
interval.Page 3 of 8
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± 27.5 μmol/L in those patients who did not develop AKI (P <
0.001). The increase in serum creatinine was sustained for at
least 72 hours after CPB, suggesting the presence of intrinsic
AKI rather than a prerenal aetiology. In Table 2, we present the
concentration of urinary IL-18 comparing patients developing
AKI with those who did not. Preoperatively, urinary IL-18 was
virtually undetectable. There were no differences in urinary IL-
18 on arrival in ICU and at 24 hours postoperatively, even
when adjusted for urinary creatinine concentration (Table 2). In
Figures 1, 2, 3, 4, we show the AUC-ROCC for the prediction
of AKI for urinary IL-18 and urinary IL-18/urinary creatinine
ratio on arrival in ICU and at 24 hours, respectively. The pre-
dictive performance of urinary IL-18 was not better than
chance at either time point (Figures 1 and 2), even after adjust-
ment for urinary creatinine concentration (Figures 3 and 4).
Even when using a variety of additional renal outcome meas-
ures in an exploratory analysis (>25% increase in creatinine,
changes in creatinine to 72 hours or 5 days, sustained
increase of greater than 50%, sustained increase of greater
than 25%, and a variety of the RIFLE criteria [14]) or the serum
creatinine criterion defining AKI according to the network clas-
sification [15], the AUC-ROCC for IL-18 was not greater than
0.61 (Tables 3, 4, 5, 6). Serum creatinine measured on arrival
Table 1
Preoperative characteristics of and intraoperative interventions in patients
Characteristics AKI (n = 20) No AKI (n = 80) P value
Demographic data
Age, years 75.3 ± 4.1 68.1 ± 9.7 <0.001
Female, number (percentage) 6 (30.0) 33 (41.0) 0.36
Body mass index 29.7 ± 4.3 27.4 ± 4.5 0.045
Comorbidities
Preoperative serum creatinine, μmol/L 96.1 ± 31.6 89.4 ± 24.0 0.30
Preoperative estimated glomerular filtration rate < 60 mL/minute, number (percentage) 8 (40.0) 19 (23.8) 0.14
Left ventricular dysfunction (ejection fraction < 40%), number (percentage) 7 (35.0) 18 (22.5) 0.25
Arterial hypertension, number (percentage) 20 (100.0) 64 (80.0) 0.029
Hypercholesterolemia, number (percentage) 16 (80.0) 46 (57.5) 0.06
Atrial fibrillation, number (percentage) 10 (50.0) 16 (20.0) 0.006
Myocardial infarction (within 6 months preoperatively), number (percentage) 7 (35.0) 13 (16.3) 0.06
Chronic obstructive pulmonary disease, number (percentage) 6 (30.0) 8 (10.0) 0.021
Peripheral vascular disease, number (percentage) 4 (20.0) 2 (2.5) 0.013
Diabetes mellitus, number (percentage)a 8 (40.0) 20 (25.0) 0.18
Intervention
Coronary artery bypass grafting surgery, number (percentage) 7 (35.0) 18 (22.5) 0.25
Valvular surgery, number (percentage) 7 (35.0) 45 (56.3) 0.09
Simultaneous coronary revascularisation and valve surgery, number (percentage) 6 (30.0) 11 (13.8) 0.08
Duration of cardiopulmonary bypass (minutes) 147.0 ± 31.6 136.0 ± 41.0 0.20
Fluid intake, 0–24 hours, mLb 5,500 ± 1,900 5,150 ± 1,250 0.44
Urine output, 0–24 hours, mL 3,350 ± 1,050 3,990 ± 1,500 0.034
Furosemide dose, 0–24 hours, mg 133.9 ± 168.7 30.9 ± 34.8 <0.001
Outcomes
Need for renal replacement therapy or died during hospital stay, number (percentage) 4 (20.0) 1 (1.3) 0.005
Ventilation, days 2.4 ± 3.1 0.9 ± 0.8 0.010
Length of stay in the intensive care unit, days 6.3 ± 7.1 2.3 ± 2.1 0.012
Length of stay in hospital, days 16.2 ± 13.8 9.5 ± 4.7 0.026
aDiabetes mellitus includes patients on antidiabetic medication and on insulin. bCrystalloids, colloids, and oral fluids from the commencement of 
cardiopulmonary bypass to 24 hours thereafter. AKI, acute kidney injury.Page 4 of 8
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Postoperative urinary interleukin-18 (IL-18) concentration
Urinary IL-18 AKI (n = 20) No AKI (n = 80) P value
Unadjusted values
Preoperative, pg/mL 0 (0–25) 0 (0–44) 0.28
On arrival in the intensive care unit, pg/mL 168 (19–736) 104 (36–292) 0.70
At 24 hours postoperatively, pg/mL 195 (54–537) 165 (42–288) 0.47
Values adjusted for urinary creatinine
Preoperative, pg/mg 0 (0–12) 0 (0–32) 0.32
On arrival in the intensive care unit, pg/mg 332 (44–1,789) 233 (86–531) 0.57
At 24 hours postoperatively, pg/mg 190 (75–478) 124 (41–245) 0.25
Values denoting median and 25th to 75th percentiles. P values indicate Mann-Whitney U test. AKI, acute kidney injury.
Table 3
Performance characteristics of urinary interleukin-18 (IL-18) according to different renal outcome definitions
Variables AUC-ROCC (95% CI) P value
Increase in serum creatinine > 25% within 24 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.58 (0.46–0.71) 0.19
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.56 (0.43–0.69) 0.34
Increase in serum creatinine > 50% within 24 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.56 (0.38–0.74) 0.51
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.57 (0.40–0.73) 0.45
Increase in serum creatinine > 25% within 48 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.59 (0.47–0.71) 0.14
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.56 (0.43–0.68) 0.36
Increase in serum creatinine > 50% within 48 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.53 (0.38–0.68) 0.70
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.55 (0.40–0.71) 0.48
Increase in serum creatinine > 25% within 72 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.60 (0.39–0.71) 0.63
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.58 (0.44–0.72) 0.55
Increase in serum creatinine > 50% within 72 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.58 (0.36–0.66) 0.85
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.55 (0.41–0.69) 0.50
Increase in serum creatinine > 25% within 120 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.60 (0.48–0.72) 0.10
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.59 (0.47–0.71) 0.14
Increase in serum creatinine > 50% within 120 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.52 (0.38–0.67) 0.78
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.56 (0.43–0.70) 0.38
AUC-ROCC, area under the curve for the receiver operating characteristic curve; CI, confidence interval.Page 5 of 8
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interval 0.54 to 0.85; P = 0.019) to predict AKI (defined as a
creatinine increase of greater than 50% within 48 hours post-
operatively) than urinary IL-18 at that time of measurement.
However, urinary IL-18 correlated with the duration of CPB
(Spearman correlation coefficient 0.47; P < 0.001).
Discussion
In this prospective observational cohort study of 100 adult car-
diac surgical patients, we analysed the predictive performance
for AKI of early postoperative urinary IL-18 measurement on
arrival in ICU and at 24 hours after commencement of CPB. In
this setting, urinary IL-18 did not appear to be a useful
biomarker for the prediction of AKI. AKI after CPB is associ-
ated with adverse hospital outcomes. Patients who develop
AKI have increased morbidity and hospital mortality [1,2]. Early
measurement of serum creatinine is considered to be of lim-
ited value in the prediction of AKI because it typically increases
only when the glomerular filtration rate has decreased to less
than 50% of normal [7,15]. Urinary IL-18, however, appears to
have value in the prediction of AKI [6,10-13]. It has been dem-
onstrated in renal tubular epithelial cells and in activated mac-
rophages [8,16]. However, urinary IL-18, a promising renal
biomarker for the early diagnosis of AKI in children undergoing
cardiac surgery, has not yet been investigated in adult cardiac
surgical patients.
The good predictive performance of urinary IL-18 for the diag-
nosis of AKI in a recent study of paediatric cardiac surgical
patients [13] was not confirmed for adults in this study. How-
ever, in paediatric cardiac surgical patients, comorbidities do
not play such a major and confounding role compared with
adults. Adult cardiac surgical patients often present with age-
related comorbidities and with diminished renal reserve.
Accordingly, observations made in paediatric populations may
not apply to adult patients. This appears to be the case for uri-
nary IL-18.
Our negative findings are in accordance with a previous study
investigating the value of urinary IL-18 in the prediction of AKI
following exposure to contrast for coronary intervention in
adult patients [9]. While it is conceivable that the very early
peak urinary IL-18 concentration was missed in this study [9]
– even when measured (as we did) at an early stage (6 hours
after the injurious event to the kidney commenced) – urinary IL-
18 was not able to predict AKI. It is nonetheless important to
note that patients undergoing CPB who did not develop AKI
had elevated postoperative urinary IL-18 concentrations com-
pared with preoperative values. There are at least three possi-
ble explanations: (a) all patients undergoing CPB suffer mild
AKI, which resolves quickly and does not lead to any elevation
in serum creatinine; or (b) urinary IL-18 increases independ-
ently of kidney injury, due to nonrenal factors such as systemic
inflammation; or (c) both explanations apply. Indeed, we found
Table 4
Performance characteristics of urinary interleukin-18 (IL-18) according to different RIFLE criteria
Variables AUC-ROCC (95% CI) P value
RIFLE R or worse (R: n = 31 + I: n = 13 + F: n = 6)
Urinary IL-18 on arrival in the intensive care unit 0.61 (0.48–0.74) 0.12
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.57 (0.43–0.71) 0.30
RIFLE I or worse (I: n = 13 + F: n = 6)
Urinary IL-18 on arrival in the intensive care unit 0.52 (0.38–0.68) 0.35
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.58 (0.43–0.73) 0.28
For RIFLE classes [14], serum creatinine increases within 120 hours postoperatively and urinary output during the first 24 hours postoperatively. AUC-
ROCC, area under the curve for the receiver operating characteristic curve; CI, confidence interval; RIFLE, Risk of renal dysfunction, Injury to the kidney, 
Failure of kidney function, Loss of kidney function, and End-stage kidney disease; RIFLE F, RIFLE Failure; RIFLE I, RIFLE Injury; RIFLE R, RIFLE Risk.
Table 5
Performance characteristics of urinary interleukin-18 (IL-18) according to different network criteria of acute kidney injury
Variables AUC-ROCC (95% CI) P value
AKIN stage 1 or worse (n = 32)
Urinary IL-18 on arrival in the intensive care unit 0.48 (0.35–0.61) 0.80
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.59 (0.46–0.72) 0.15
Acute kidney injury defined according to the network criteria [15] with serum creatinine increase of greater than 26.4 μmol/L or greater than 0.3 mg/dL 
within 48 hours postoperatively. AKIN, Acute Kidney Injury Network; AUC-ROCC, area under the curve for the receiver operating characteristic curve; CI, 
confidence interval.Page 6 of 8
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18. On the basis of our findings, increases in urinary IL-18 may
indicate renal epithelial tubular cell injury in adult cardiac sur-
gical patients, which is not severe enough to predictably lead
to loss of glomerular filtration rate. Thus, urinary IL-18 is poten-
tially a nonspecific marker of inflammation and not a specific
marker for AKI. Indeed, IL-18 is released by both renal tubular
cells and macrophages or blood monocytes and is then fil-
tered through the glomerular basal membrane. The latter
source, however, is believed to represent the main origin of IL-
18 in adults [8]. If this were true, it would potentially confound
the value of urinary IL-18 as a specific renal biomarker and at
least partly explain our observations. In children, release of IL-
18 may proceed primarily through the kidney rather than
immune cells, thus explaining the better predictive ability of IL-
18. Irrespective of the possible explanation, our observations
highlight the need to study the value of renal biomarkers in
adult cardiac surgical patients separately.
This is a single-centre study and its findings need to be con-
firmed or refuted in other centres. While it is conceivable that
a larger sample size or more frequent measurement might have
generated statistically significant findings on urinary IL-18, the
study sample size is sufficient for the detection of a major and
clinically relevant predictive performance of this renal biomar-
ker. Although we enrolled a patient population with a typical
mix of cardiac surgical procedures, it is possible that urinary IL-
18 would be of greater value in patients at increased risk of
developing AKI. In the absence of adjudication of aetiology,
the sustained increase in serum creatinine may exclude, at
least in part, haemodynamic/prerenal causes of AKI, for which
no increase in urinary IL-18 would be expected. Also, worse
outcome in patients developing AKI (as defined) compared
with those who did not develop AKI points to intrinsic rather
than prerenal azotaemia. We consider that additional novel
biomarkers with increased predictive performance are still
needed for more precise and earlier prediction of AKI after
adult cardiac surgery.
Conclusion
This is the first study to test the value of urinary IL-18 as a pre-
dictor of AKI following adult cardiac surgery with CPB. Our
findings suggest that, although urinary IL-18 may be a marker
of CPB-associated inflammation, it is not useful in identifying
patients who will subsequently develop AKI after adult cardiac
surgery.
Table 6
Performance characteristics of urinary interleukin-18 (IL-18) to predict the development of sustained acute kidney injury
Variables AUC-ROCC (95% CI) P value
Increase in serum creatinine > 25% within 48 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.58 (0.46–0.71) 0.19
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.56 (0.43–0.69) 0.43
Increase in serum creatinine > 50% within 48 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.56 (0.38–0.74) 0.51
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.57 (0.40–0.73) 0.45
Increase in serum creatinine > 25% within 120 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.59 (0.47–0.71) 0.14
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.56 (0.43–0.68) 0.36
Increase in serum creatinine > 50% within 120 hours postoperatively
Urinary IL-18 on arrival in the intensive care unit 0.51 (0.34–0.67) 0.93
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.57 (0.42–0.73) 0.36
RIFLE R or worse (R: n = 31 + I: n = 13 + F: n = 6)
Urinary IL-18 on arrival in the intensive care unit 0.61 (0.48–0.74) 0.12
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.57 (0.43–0.71) 0.29
RIFLE I or worse (I: n = 13 + F: n = 6)
Urinary IL-18 on arrival in the intensive care unit 0.52 (0.37–0.67) 0.30
Urinary IL-18 at 24 hours after cardiopulmonary bypass 0.58 (0.43–0.73) 0.28
Acute kidney injury is defined as at least two consecutive significantly increased serum creatinine values. For RIFLE classes, serum creatinine increases 
within 120 hours postoperatively and urinary output during the first 24 hours postoperatively. AUC-ROCC, area under the curve for the receiver operating 
characteristic curve; CI, confidence interval; RIFLE, Risk of renal dysfunction, Injury to the kidney, Failure of kidney function, Loss of kidney function, and 
End-stage kidney disease; RIFLE F, RIFLE Failure; RIFLE I, RIFLE Injury; RIFLE R, RIFLE Risk.Page 7 of 8
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Key messages
• Urinary interleukin-18 (IL-18) measured on arrival in the 
intensive care unit and at 24 hours postoperatively does 
not predict acute kidney injury in adult cardiac surgical 
patients.
• Urinary IL-18 appears instead to be a marker of inflam-
mation in this setting.Page 8 of 8
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